ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.71
+4.27%Margins
Gross margin
67.6%
EBITDA margin
-1.0%
EBIT margin
-6.4%
Net margin
-19.8%
FCF margin
4.6%
-31.3%
Return on equity
-22.2%
Return on assets
-8.2%
Return on invested capital
0.99x
Asset turnover
$32.0M
Cash from operations
$0.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026